Suppression of myopia progression by low dose atropine

Suppression of myopia progression by low dose atropine - Suppression of myopia progression by low dose atropine

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028768

Enrollment

Registered

2017-08-25

Start date

2014-02-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Myopia

Interventions

0.01% atropine Once a day 4 year Single vision lenses Single vision lenses

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Spherical equivalent -1.50D~-4.50D Astigmatism of less than 1.5D

Exclusion criteria

Exclusion criteria: A case with ocular disease other than myopia

Design outcomes

Primary

Measure	Time frame
Myopia progression at 4 year Cycloplegic subjective refraction Axial length	—

Secondary

Measure	Time frame
Distance best-corrected visual acuity logMAR Near visual acuity was assessed using best corrected distance spectacle correction with a reduced logMAR reading chart Pupil diameter Accommodation amplitude	—

Countries

Japan

Contacts

Public ContactYuki Nishiyama

Tokyo Medical and Dental University Ophthalmology&Visual Science

ynishiyama-tmd@umin.ac.jp03-3813-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026